Drugs / rVSVΔG-SUDV-GP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07565090 | May 2026 → Apr 2027 expected | infectious disease | International AIDS Vaccine Initiative | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rVSVΔG-SUDV-GP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07565090 ↗ |
| Modality | Vaccine | “rVSVΔG-SUDV-GP Vaccine” NCT07565090 ↗ |